The Revlon Requiem: Why the Chancery Court’s Exemption for Public Benefit Corporations Radically Rewrites M&A Fiduciary Duties

The Death of the Auctioneer for the Mission-Driven Board

For nearly forty years, the bedrock of Delaware mergers and acquisitions law has been defined by a single, unyielding mandate: when a corporation is up for sale, the board of directors must become auctioneers charged with getting the highest possible price for stockholders. But on July 29, 2026, the Delaware Court of Chancery officially blew a statutory hole through that sacrosanct doctrine, ruling that Public Benefit Corporations (PBCs) are not legally required to maximize sale price in a change-of-control transaction.

This ruling, which confirmed that PBC directors must continue to balance stockholder value with other public-benefit interests even during a buyout, is the most consequential structural shift in Delaware deal litigation in a decade. For the corporate defense bar, it is a brilliant validation of the PBC form. For institutional investors and plaintiffs’ attorneys, it is a terrifying new shield that entrenched boards can use to justify leaving money on the table.

Colliding Doctrines: Revlon Meets Section 365

To understand why this Chancery decision is a seismic event for practicing deal lawyers, one must look at the inevitable collision between Delaware’s most famous common-law doctrine and its relatively new statutory creature.

Under Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986), a board’s fiduciary duties fundamentally shift when a company enters a cash sale or change of control. The preservation of the corporate entity is no longer the goal; the sole focus becomes maximizing short-term stockholder value. The board’s defensive measures and deal protections are scrutinized under enhanced reasonableness to ensure they aren't chilling superior bids.

But the Public Benefit Corporation, governed by Subchapter XV of the Delaware General Corporation Law, inherently rejects stockholder primacy. Under Del. Code Ann. tit. 8, § 365, PBC directors are statutorily mandated to balance three competing interests: the pecuniary interests of the stockholders, the best interests of those materially affected by the corporation’s conduct, and the specific public benefit identified in the charter.

The July 29 ruling answers the multi-billion-dollar question that has haunted dealmakers since the PBC statute was enacted: Does Revlon mode override the Section 365 balancing requirement? The Chancery Court’s answer is a resounding "no."

"The statutory mandate of a Public Benefit Corporation does not evaporate the moment the company is put into play. To impose traditional Revlon duties on a PBC board would require directors to violate their foundational charter and ignore the very stakeholders they are legally bound to protect."

The Moral Hazard of the "Mission-Driven" Discount

From a purely textualist perspective, the Chancery Court got it right. The legislature drafted Section 365 as a continuous obligation. However, from a practical, governance perspective, this ruling introduces a staggering moral hazard into M&A negotiations.

Consider the immediate implications for a hostile takeover or a competing bid scenario. A PBC board receives a $50-per-share offer from an aggressive private equity firm known for stripping assets and laying off workers. A competing "friendly" buyer, who promises to maintain the company’s environmental mission and protect the workforce, bids $42 per share. Under traditional Revlon scrutiny, accepting the $42 bid would be a flagrant breach of fiduciary duty. Under this new Chancery precedent, the board can legally accept the lower bid, citing its statutory duty to balance the "materially affected" stakeholders and the corporate mission against the stockholders' pecuniary interests.

This effectively hands corporate boards a judicially blessed, structural poison pill. By converting to a PBC—which currently only requires a majority stockholder vote under recent DGCL amendments—management can insulate their preferred deal structures from Revlon scrutiny.

Practice Impacts: Rewriting the Deal Playbook

For transactional lawyers and litigators, this ruling immediately changes how public company deals are structured, negotiated, and challenged:

1. Deal Certainty for the "Good" Buyer: Buyers who are willing to commit to post-closing covenants regarding a target's public benefit will suddenly find themselves with immense leverage. M&A counsel should begin drafting aggressive "mission continuity" clauses in merger agreements, allowing target boards to point to these covenants as justification for selecting a bid that might not carry the highest premium.

2. The Death of the Revlon Injunction: Plaintiffs’ firms relying on the traditional playbook—suing to enjoin a transaction based on a flawed auction process or failure to maximize price—will find their claims dead on arrival if the target is a PBC. The standard of review shifts from enhanced scrutiny back to the highly deferential business judgment rule, provided the board can show it engaged in a rational balancing of interests.

3. A Surge in Appraisal Arbitrage: If stockholders cannot sue for breach of fiduciary duty over a suboptimal sale price, their only remaining recourse is statutory appraisal under Del. Code Ann. tit. 8, § 262. We can expect a significant migration of plaintiff-side capital away from fiduciary duty class actions and toward appraisal arbitrage when PBCs are acquired, as dissenting shareholders seek fair value determinations independent of the board’s "mission-driven" discount.

The Bottom Line

The Chancery Court has officially recognized that the Public Benefit Corporation is not just an ESG marketing gimmick—it is a fundamentally different legal vehicle that fundamentally alters the DNA of Delaware fiduciary duties. While the ruling provides much-needed clarity for ESG-focused founders, it strips institutional investors of their most potent weapon in change-of-control transactions. Revlon is no longer the inescapable gravity of Delaware M&A; for the PBC, it is officially a relic of the past.